These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33348008)

  • 21. Duration of blood flow reversal during transcarotid artery revascularization does not affect outcome.
    Kumins NH; King AH; Jim J; Motaganahalli RL; Apple JM; Foteh MI; Cho JS; Kashyap VS
    J Vasc Surg; 2020 Aug; 72(2):584-588. PubMed ID: 31901361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization.
    Ghamraoui AK; Ricotta JJ
    J Vasc Surg; 2021 Jan; 73(1):132-141. PubMed ID: 32445834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clopidogrel versus ticagrelor for antiplatelet therapy in transcarotid artery revascularization in the Society for Vascular Surgery Vascular Quality Initiative.
    Ghamraoui AK; Chang H; Maldonado TS; Ricotta JJ
    J Vasc Surg; 2022 May; 75(5):1652-1660. PubMed ID: 34920001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of transfemoral carotid artery stenting with proximal balloon occlusion embolic protection in the contemporary endovascular management of carotid artery stenosis.
    Liang P; Soden P; Wyers MC; Malas MB; Nolan BW; Wang GJ; Powell RJ; Schermerhorn ML
    J Vasc Surg; 2020 Nov; 72(5):1701-1710. PubMed ID: 32251772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protamine use in transcarotid artery revascularization is associated with lower risk of bleeding complications without higher risk of thromboembolic events.
    Liang P; Motaganahalli RL; Malas MB; Wang GJ; Eldrup-Jorgensen J; Cronenwett JL; Nolan BW; Kashyap VS; Schermerhorn ML
    J Vasc Surg; 2020 Dec; 72(6):2079-2087. PubMed ID: 32273225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular Quality Initiative risk score for 30-day stroke or death following transcarotid artery revascularization.
    Liang P; O'Donnell TFX; Cronenwett JL; Malas MB; Eldrup-Jorgensen J; Kashyap VS; Wang GJ; Motaganahalli RL; Nolan BW; Schermerhorn ML
    J Vasc Surg; 2021 May; 73(5):1665-1674. PubMed ID: 33091519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endovascular stenting of supra-aortic lesions using a transcarotid retrograde approach and flow reversal: A multicenter case series.
    Balceniuk MD; Hosn MA; Corn RS; DerDerian T; Grimsley BR; Long P; Moore WS; Rossi PJ; Shakir HJ; Siddiqui AH; Spadone DP; Waqas M; Stoner MC
    J Vasc Surg; 2020 Jun; 71(6):2012-2020.e18. PubMed ID: 31740187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carotid stenosis patients with a remote history of cerebrovascular events have increased risk of major adverse events over asymptomatic patients.
    Turner AD; Zhu J; Rao A; Ting W; Han D; Tadros R; Finlay D; Vouyouka A; Phair J; Marin M; Faries P
    J Vasc Surg; 2022 Dec; 76(6):1625-1632. PubMed ID: 35868422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-layered micromesh stent technology for embolic prevention in carotid revascularization: technical experience and clinical outcomes from a high-volume interventional radiology center.
    Stefanini M; Cacioppa LM; Bellini L; Ginanni Corradini L; D'Onofrio A; Simonetti G
    J Cardiovasc Surg (Torino); 2024 Jun; 65(3):213-220. PubMed ID: 38727642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of carotid lesion calcification on outcomes of carotid artery stenting.
    Elsayed N; Yei KS; Naazie I; Goodney P; Clouse WD; Malas M
    J Vasc Surg; 2022 Mar; 75(3):921-929. PubMed ID: 34592377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Transcarotid Artery Revascularization and Transfemoral Carotid Artery Stenting Based on High Risk Anatomic Characteristics.
    Zhu J; Rao A; Ting W; Han D; Tadros R; Finlay D; Phair J; Vouyouka A; Liu H; Marin M; Faries P
    Ann Vasc Surg; 2022 Nov; 87():21-30. PubMed ID: 35398198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of timing on in-hospital and one-year outcomes after transcarotid artery revascularization.
    Cui CL; Dakour-Aridi H; Eldrup-Jorgensen J; Schermerhorn ML; Siracuse JJ; Malas MB
    J Vasc Surg; 2021 May; 73(5):1649-1657.e1. PubMed ID: 33038481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-frequency avoidable errors during transcarotid artery revascularization.
    Teter K; Lamparello PJ; Barfield M; Rockman CB; Macdonald S; Maldonado TS
    J Vasc Surg; 2021 May; 73(5):1658-1664. PubMed ID: 33065241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of transcarotid revascularization with dynamic flow reversal versus carotid endarterectomy in the TCAR Surveillance Project.
    Dakour-Aridi H; Ramakrishnan G; Zarrintan S; Malas MB
    Semin Vasc Surg; 2020; 33(1-2):24-30. PubMed ID: 33218613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative outcomes for carotid revascularization on asymptomatic dialysis-dependent patients meet Society for Vascular Society guidelines.
    Latz CA; Boitano LT; Wang LJ; DeCarlo C; Pendleton AA; Waller HD; Lee CJ; Dua A
    J Vasc Surg; 2021 Jul; 74(1):195-202. PubMed ID: 33340696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Feasibility of Simultaneous Transcarotid Revascularization With Flow Reversal and Coronary Artery Bypass Grafting for Concomitant Carotid Artery Stenosis and Coronary Artery Disease.
    Williams Z; Olivere LA; Gilmore B; Weissler H; Cox MW; Long C; Shortell CK; Schroder J; Southerland KW
    Vasc Endovascular Surg; 2020 Jul; 54(5):395-399. PubMed ID: 32319354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Adoption of Transcarotid Artery Revascularization With Center-Level Perioperative Outcomes.
    Columbo JA; Martinez-Camblor P; O'Malley AJ; Stone DH; Kashyap VS; Powell RJ; Schermerhorn ML; Malas M; Nolan BW; Goodney PP
    JAMA Netw Open; 2021 Feb; 4(2):e2037885. PubMed ID: 33616666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trial.
    Kashyap VS; So KL; Schneider PA; Rathore R; Pham T; Motaganahalli RL; Massop DW; Foteh MI; Eckstein HH; Jim J; Leal Lorenzo JI; Melton JG
    J Vasc Surg; 2022 Aug; 76(2):466-473.e1. PubMed ID: 35381327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propensity-Matched Outcomes of Transcarotid Artery Revascularization Versus Carotid Endarterectomy.
    Yee EJ; Wang SK; Timsina LR; Ruiz-Herrera S; Liao JL; Donde NN; Fajardo AC; Motaganahalli RL
    J Surg Res; 2020 Aug; 252():22-29. PubMed ID: 32222590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of Transcarotid Revascularization in Patients with a Contraindication to Dual Antiplatelets.
    Olvera A; Tanaka A; Madison MK; Motaganahalli RL; Fajardo A; Keyhani A; Keyhani K; Wang SK
    Vasc Endovascular Surg; 2022 Nov; 56(8):746-753. PubMed ID: 35793240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.